CRIS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Curis Inc (CRIS) does not present a compelling buy opportunity for a beginner investor with a long-term focus at this time. Despite a slight positive price movement in the regular market, the company's financial performance shows significant declines in net income, EPS, and gross margin. Additionally, there are no strong technical signals or recent positive news catalysts to justify immediate investment. Analysts' ratings and price targets are not directly related to CRIS, and there are no recent trading trends or influential figures involved with the stock.
The MACD histogram is positive but contracting, RSI is neutral at 60.937, and moving averages are converging, indicating no strong trend. Key support and resistance levels are Pivot: 1.117, R1: 1.181, S1: 1.054, R2: 1.22, S2: 1.015. Overall, technical indicators suggest a neutral stance.
NULL identified. No recent news or significant trading trends. The stock has shown slight positive price movement in the regular market but lacks strong catalysts.
The company's financials for Q3 2025 show a YoY decline in net income (-23.41%), EPS (-71.18%), and gross margin (-31.34%). Additionally, there is no recent congress trading data or influential figure involvement.
In Q3 2025, revenue increased by 8.36% YoY to $3.176M, but net income dropped to -$7.729M (-23.41% YoY). EPS fell to -0.49 (-71.18% YoY), and gross margin declined to 71.66% (-31.34% YoY). Overall, financial performance indicates significant challenges.
No direct analyst ratings or price targets for CRIS. The provided analyst ratings and price targets are for Caris Life Sciences, which is unrelated to CRIS.
